Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2021 Results – Earnings Call Transcript

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET
Company Participants
Jennifer Good – President and Chief Executive Officer
Bill Forbes – Chief Development Officer
Conference Call Participants
Serge Belanger…

Click here to view the original article.